Guardant Health
GH
#2398
Rank
S$8.34 B
Marketcap
$67.55
Share price
4.81%
Change (1 day)
126.58%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -S$0.68 Billion

According to Guardant Health 's latest financial reports the company's current earnings are S$0.69 Billion. In 2023 the company made an earning of -S$0.65 Billion, an increase over its 2022 earnings that were of -S$0.89 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.68 Billion4.9%
2023 -S$0.65 Billion-26.73%
2022 -S$0.89 Billion69.96%
2021 -S$0.53 Billion56.35%
2020 -S$0.34 Billion252.69%
2019 -S$94.31 Million-17.22%
2018 -S$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.29 Billion-58.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$42.72 Million-93.84%๐Ÿ‡บ๐Ÿ‡ธ USA